The Discounted Cash Flow (DCF) valuation of Catalyst Pharmaceuticals Inc (CPRX) is 18.98 USD. With the latest stock price at 21.97 USD, the upside of Catalyst Pharmaceuticals Inc based on DCF is -13.6%.
| Range | Selected | |
| WACC / Discount Rate | 7.7% - 9.7% | 8.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 14.71 - 29.34 | 18.98 |
| Upside | -33.0% - 33.5% | -13.6% |